MedPath

Comparison of Three Meshes in Lichtenstein Hernia Repair

Not Applicable
Completed
Conditions
Chronic Pain
Recurrences
Interventions
Device: Vypro II mesh
Device: Premilene LP
Device: Premilene mesh
Registration Number
NCT01295437
Lead Sponsor
Kuopio University Hospital
Brief Summary

Chronic pain may be a long-term problem after inguinal Lichtenstein hernioplasty. The aim of this study was to compare long-term results of hernioplasty using three different meshes (partly absorbable, lightweight polypropylene and thick polypropylene mesh).

Detailed Description

Inguinal hernioplasty was performed under local anesthesia in 300 patients in day-case surgery by the same surgeon and exactly by the same surgical technique. The patients were randomized to receive either a partly polypropylene-polyglactin mesh (Vypro II, 100 hernias), a lightweight polypropylene mesh (Premilene LP, 100 hernias) or a conventional densely woven polypropylene mesh (Premilene, 100 hernias). Pain, patients discomfort and recurrences of hernias were carefully followed 5 years after surgery.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • uni-or bilateral primary or recurrent inguinal hernia
  • patients age >18yrs
Exclusion Criteria
  • previous mesh hernioplasty
  • femoral hernia
  • emergency operation
  • allergy to polypropylene

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vypro II meshVypro II meshA partly absorbable polypropylene-polyglactin mesh (50g/m2).
Premilene LPPremilene LPA lightweight polypropylene mesh (55 g/m2)
Premilene meshPremilene meshA conventional polypropylene mesh (82 g/m2)
Primary Outcome Measures
NameTimeMethod
Presence of chronic pain5 years

Pain scores were measured by using a visual analoque scale.

Secondary Outcome Measures
NameTimeMethod
Presence of recurrences5 years

Recurrence of inguinal hernias after Lichtenstein hernioplasty was studies during clinical and ultrasound examination

Trial Locations

Locations (1)

Hannu Paajanen

🇫🇮

Kuopio, Finland

© Copyright 2025. All Rights Reserved by MedPath